chrM-15071-T-C

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4BP6_Very_StrongBS2

The ENST00000361789.2(MT-CYB):​c.325T>C​(p.Tyr109His) variant causes a missense change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. 4/4 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Mitomap GenBank:
𝑓 0.0018 ( AC: 108 )

Consequence

MT-CYB
ENST00000361789.2 missense

Scores

Apogee2
Benign
0.073

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:2
No linked disesase in Mitomap

Conservation

PhyloP100: 0.200

Publications

6 publications found
Variant links:
Genes affected
MT-CYB (HGNC:7427): (mitochondrially encoded cytochrome b) Predicted to enable metal ion binding activity. Predicted to be involved in several processes, including electron transport coupled proton transport; response to cobalamin; and response to glucagon. Located in mitochondrion. Implicated in ovarian carcinoma and urinary bladder cancer. [provided by Alliance of Genome Resources, Apr 2022]
MT-CYB Gene-Disease associations (from GenCC):
  • mitochondrial disease
    Inheritance: Mitochondrial Classification: DEFINITIVE Submitted by: ClinGen
  • mitochondrial complex III deficiency
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • Leber hereditary optic neuropathy
    Inheritance: Mitochondrial Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript ENST00000361789.2, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Apogee2 supports a benign effect, 0.07268605 < 0.5 .
BP6
Variant M-15071-T-C is Benign according to our data. Variant chrM-15071-T-C is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 445709.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High AC in GnomadMitoHomoplasmic at 55

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000361789.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt

There are no transcript annotations for this variant.

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MT-CYB
ENST00000361789.2
TSL:6
c.325T>Cp.Tyr109His
missense
Exon 1 of 1ENSP00000354554.2P00156

Frequencies

Mitomap GenBank
AF:
0.0018
AC:
108
Gnomad homoplasmic
AF:
0.00097
AC:
55
AN:
56430
Gnomad heteroplasmic
AF:
0.000071
AC:
4
AN:
56430
Alfa
AF:
0.00136
Hom.:
69

Mitomap

No disease associated.

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
Leigh syndrome (1)
-
-
1
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
Apogee2
Benign
0.073
Hmtvar
Benign
0.26
AlphaMissense
Benign
0.079
PhyloP100
0.20
Mutation Taster
=90/10
polymorphism

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs199999794;
hg19: chrM-15072;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.